The Cognizant® Shared Investigator Platform (SIP) Document Exchange Module

The global pandemic has compelled the life sciences industry to reimagine how to proceed with clinical research and development in an environment stymied by emergency restrictions. Despite unprecedented obstacles, the industry survived and thrived, accomplishing in approximately 12 months what has historically taken years. However, life sciences organizations still have to contend with the perennial challenge of reducing the cost of bringing therapies to market while shortening the time between discovery and regulatory approvals. In fact, the emerging landscape has placed heightened expectations on organizations for speed to market and operational efficiency in addition to cost pressures.